A Feedback Loop Involving the Phd3 Prolyl Hydroxylase Tunes the Mammalian Hypoxic Response In Vivo
暂无分享,去创建一个
W. Kaelin | R. Bronson | R. Liao | J. Moslehi | R. Padera | Y. Minamishima
[1] E. Rankin,et al. Hypoxia-Inducible Factor 2 Regulates Hepatic Lipid Metabolism , 2009, Molecular and Cellular Biology.
[2] F. Galateau-Sallé,et al. PHD2 mutation and congenital erythrocytosis with paraganglioma. , 2008, The New England journal of medicine.
[3] W. Kaelin,et al. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. , 2008, Molecular cell.
[4] G. Semenza. Mitochondrial autophagy: Life and breath of the cell , 2008, Autophagy.
[5] K. Rantanen,et al. Prolyl hydroxylase PHD3 activates oxygen-dependent protein aggregation. , 2008, Molecular biology of the cell.
[6] G. Semenza,et al. Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to Hypoxia* , 2008, Journal of Biological Chemistry.
[7] L. Kirshenbaum,et al. Molecular regulation of autophagy and apoptosis during ischemic and non-ischemic cardiomyopathy , 2008, Autophagy.
[8] M. Meyerson,et al. The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. , 2008, Genes & development.
[9] K. Takeda,et al. Role and regulation of prolyl hydroxylase domain proteins , 2008, Cell Death and Differentiation.
[10] K. Takeda,et al. Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins. , 2008, Blood.
[11] W. Kaelin,et al. Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. , 2008, Blood.
[12] R. Johnson,et al. Hypoxia-Inducible Factor-Dependent Degeneration, Failure, and Malignant Transformation of the Heart in the Absence of the von Hippel-Lindau Protein , 2008, Molecular and Cellular Biology.
[13] Robert A. Harris,et al. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism , 2008, Nature Genetics.
[14] B. Volpe,et al. Harnessing hypoxic adaptation to prevent, treat, and repair stroke , 2007, Journal of Molecular Medicine.
[15] R. Shohet,et al. Keeping the engine primed: HIF factors as key regulators of cardiac metabolism and angiogenesis during ischemia , 2007, Journal of Molecular Medicine.
[16] J. Tisdale,et al. HIF prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques. , 2007, Blood.
[17] M. McMullin,et al. A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove. , 2007, Blood.
[18] Oxana V. Baranova,et al. Neuron-Specific Inactivation of the Hypoxia Inducible Factor 1α Increases Brain Injury in a Mouse Model of Transient Focal Cerebral Ischemia , 2007, The Journal of Neuroscience.
[19] S. Bartz,et al. The Hypoxia-Inducible Factor 2α N-Terminal and C-Terminal Transactivation Domains Cooperate To Promote Renal Tumorigenesis In Vivo , 2007, Molecular and Cellular Biology.
[20] R. Gottlieb,et al. Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy , 2007, Cell Death and Differentiation.
[21] B. Ebert,et al. Failure to prolyl hydroxylate hypoxia‐inducible factor α phenocopies VHL inactivation in vivo , 2006 .
[22] K. Takeda,et al. Placental but Not Heart Defects Are Associated with Elevated Hypoxia-Inducible Factor α Levels in Mice Lacking Prolyl Hydroxylase Domain Protein 2 , 2006, Molecular and Cellular Biology.
[23] Roland H Wenger,et al. Increased Prolyl 4-Hydroxylase Domain Proteins Compensate for Decreased Oxygen Levels , 2006, Journal of Biological Chemistry.
[24] Daniel J. Peet,et al. Cell-specific Regulation of Hypoxia-inducible Factor (HIF)-1α and HIF-2α Stabilization and Transactivation in a Graded Oxygen Environment* , 2006, Journal of Biological Chemistry.
[25] V. Regitz-Zagrosek,et al. Stabilization of hypoxia inducible factor rather than modulation of collagen metabolism improves cardiac function after acute myocardial infarction in rats , 2006, European journal of heart failure.
[26] M. McMullin,et al. A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[27] R. DePinho,et al. Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[28] P. Thistlethwaite,et al. Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. , 2005, Journal of the American College of Cardiology.
[29] W. Kaelin,et al. Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. , 2005, Cancer cell.
[30] E. Rankin,et al. Inactivation of the Arylhydrocarbon Receptor Nuclear Translocator (Arnt) Suppresses von Hippel-Lindau Disease-Associated Vascular Tumors in Mice , 2005, Molecular and Cellular Biology.
[31] S. Rohrbach,et al. Age-dependent increase of prolyl-4-hydroxylase domain (PHD) 3 expression in human and mouse heart , 2005, Biogerontology.
[32] A. Harris,et al. Differential Function of the Prolyl Hydroxylases PHD1, PHD2, and PHD3 in the Regulation of Hypoxia-inducible Factor* , 2004, Journal of Biological Chemistry.
[33] P. Jaakkola,et al. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. , 2004, The Biochemical journal.
[34] M. Wood,et al. Regulation of HIF prolyl hydroxylases by hypoxia‐inducible factors , 2004, Journal of cellular biochemistry.
[35] R. Johnson,et al. Cardiac myocyte‐specific HIF‐1α deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] G. Semenza. Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.
[37] A. Vortmeyer,et al. Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene. , 2003, Cancer research.
[38] J. Pouysségur,et al. HIF prolyl‐hydroxylase 2 is the key oxygen sensor setting low steady‐state levels of HIF‐1α in normoxia , 2003, The EMBO journal.
[39] K. Kivirikko,et al. Characterization of the Human Prolyl 4-Hydroxylases That Modify the Hypoxia-inducible Factor* , 2003, Journal of Biological Chemistry.
[40] W. Jelkmann,et al. Intracellular localisation of human HIF-1α hydroxylases: implications for oxygen sensing , 2003, Journal of Cell Science.
[41] Mircea Ivan,et al. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[42] Yuichi Makino,et al. Inhibitory PAS Domain Protein (IPAS) Is a Hypoxia-inducible Splicing Variant of the Hypoxia-inducible Factor-3α Locus* , 2002, The Journal of Biological Chemistry.
[43] Christopher J Schofield,et al. Hypoxia-inducible Factor (HIF) Asparagine Hydroxylase Is Identical to Factor Inhibiting HIF (FIH) and Is Related to the Cupin Structural Family* , 2002, The Journal of Biological Chemistry.
[44] D. Peet,et al. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. , 2002, Genes & development.
[45] Andrew P McMahon,et al. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. , 2002, Developmental biology.
[46] M. Taubman,et al. Mammalian EGLN genes have distinct patterns of mRNA expression and regulation. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[47] Yuichi Makino,et al. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression , 2001, Nature.
[48] G. Semenza,et al. FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. , 2001 .
[49] S. McKnight,et al. A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF , 2001, Science.
[50] Michael I. Wilson,et al. C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation , 2001, Cell.
[51] R. Jaenisch,et al. Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[52] Shigeyoshi Itohara,et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.
[53] J. Decaprio,et al. pRB-Dependent, J Domain-Independent Function of Simian Virus 40 Large T Antigen in Override of p53 Growth Suppression , 2000, Journal of Virology.
[54] J M Ward,et al. Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.